Postpartum Sleep Disturbance
Conditions
Interventions
Esketamine group:After the fetus is delivered during a cesarean section, the patient is slowly intravenously injected with 0.25mg/kg of esketamine diluted with 5ml
Control group:None
Sponsors
Tianjin Medical University General Hospital, Tianjin, China
Eligibility
Sex/Gender
Female
Age
18 Years to 44 Years
Inclusion criteria
Inclusion criteria: 1. Age 18–44 years; 2. Pregnant women at 36–42 weeks gestation, planning a cesarean section; 3. ASA classification I–III; 4. Patients who agree to voluntarily participate in this trial.
Exclusion criteria
Exclusion criteria: 1. Individuals known to be allergic to the drug components of this study or with drug contraindications; 2. ASA classification IV; patients with poorly controlled pregnancy-induced hypertension or pulmonary arterial hypertension during pregnancy; 3. Bronchial asthma, severe hypertension, serious liver and kidney dysfunction, hyperthyroidism, severe cardiovascular and cerebrovascular diseases; 4. BMI > 35 kg/m^2; 5. Poor compliance, unable to complete the trial according to the study protocol; 6. For any reason, situations deemed by the researchers as unsuitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postpartum sleep disturbance after cesarean delivery;Hospital Anxiety and Depression Scale; | — |
Countries
China
Contacts
Public ContactXie ke liang
Tianjin Medical University General Hospital
Outcome results
None listed